Retargeting adenoviral vectors to improve gene transfer into tumors

Cancer Gene Therapy

Volumn 18, Issue 4, 2011, Pages 275-287

  Hogg, R T ^a   Thorpe, P ^a   Gerard, R D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

adenovirus; bavituximab; bispecific antibody; fiber; targeting

Indexed keywords

ADENOVIRUS VECTOR; BISPECIFIC ANTIBODY; CAPSID PROTEIN; MUTANT PROTEIN; VASCULAR TARGETING AGENT; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; COMPETITIVE INHIBITION; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE TRANSFER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER TOXICITY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE INFECTION; TISSUE INTERACTION; TUMOR CELL; VIRAL TROPISM;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, BISPECIFIC; CELL LINE, TUMOR; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; NEOPLASMS; TRANSDUCTION, GENETIC; TRANSGENES;

ADENOVIRIDAE; MIRIDAE;

EID: 79952901838     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2010.78     Document Type: Article

References (55)

1. Gerard RD, Meidell RS. Adenovirus vectors. In: Hames BD, Glover D (eds). DNA Cloning: A Practical Approach. Oxford University Press: Oxford, 1995, pp 285-307.
2. Glasgow JN, Everts M, Curiel DT. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 2006; 13: 830-844.
3. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356. (Pubitemid 27157315)
4. Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, Cabrini G. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 2001; 75: 8772-8780. (Pubitemid 32768981)
5. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G. Heparan sulfate glycosaminoglycans are involved in adeno-virus type 5 and 2-host cell interactions. Virology 2000; 268: 382-390. (Pubitemid 30159987)
6. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL et al. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 2008; 105: 5483-5488. (Pubitemid 351753889)
7. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008; 132: 397-409. (Pubitemid 351200513)
8. Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, Nicklin SA et al. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 2009; 114: 965-971.
9. Kremer EJ. Mutagenesis of hexon 'FX' hepatic tropism. Blood 2009; 114: 929-930.
10. Vigant F, Descamps D, Jullienne B, Esselin S, Connault E, Opolon P et al. Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver. Mol Ther 2008; 16: 1474-1480.
11. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SL. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403-409. (Pubitemid 24308308)
12. Sharma A, Li X, Bangari DS, Mittal SK. Adenovirus receptors and their implications in gene delivery. Virus Res 2009; 143: 184-194.
13. Bayo-Puxan N, Gimenez-Alejandre M, Lavilla-Alonso S, Gros A, Cascallo M, Hemminki A et al. Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting. Hum Gene Ther 2009; 20: 1214-1221.
14. Gimenez-Alejandre M, Cascallo M, Bayo-Puxan N, Ale-many R. Coagulation factors determine tumor transduction in vivo. Hum Gene Ther 2008; 19: 1415-1419.
15. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, Denby L et al. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 2006; 108: 2554-2561.
16. Waddington SN, Parker AL, Havenga M, Nicklin SA, Buckley SM, McVey JH et al. Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J Virol 2007; 81: 9568-9571. (Pubitemid 47311502)
17. Shashkova EV, Doronin K, Senac JS, Barry MA. Macro-phage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Res 2008; 68: 5896-5904.
18. Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J Virol 2000; 74: 6875-6884. (Pubitemid 30470671)
19. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996; 14: 1574-1578. (Pubitemid 26365552)
20. Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP et al. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res 1997; 57: 1447-1451. (Pubitemid 27175559)
21. Gu DL, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M et al. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res 1999; 59: 2608-2614. (Pubitemid 29269107)
22. Kashentseva EA, Seki T, Curiel DT, Dmitriev IP. Adeno-virus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain. Cancer Res 2002; 62: 609-616. (Pubitemid 34106439)
23. Li HJ, Everts M, Pereboeva L, Komarova S, Idan A, Curiel DT et al. Adenovirus tumor targeting and hepatic untarget-ing by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter. Cancer Res 2007; 67: 5354-5361. (Pubitemid 46997275)
24. Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ et al. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther 2000; 2: 562-578.
25. Israel BF, Pickles RJ, Segal DM, Gerard RD, Kenney SC. Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. J Virol 2001; 75: 5215-5221. (Pubitemid 32448544)
26. Itoh A, Okada T, Mizuguchi H, Hayakawa T, Mizukami H, Kume A et al. A soluble CAR-SCF fusion protein improves adenoviral vector-mediated gene transfer to c-Kit-positive hematopoietic cells. J Gene Med 2003; 5: 929-940. (Pubitemid 40310418)
27. Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H et al. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J Virol 2002; 76: 1892-1903. (Pubitemid 34094636)
28. Hogg RT, Garcia JA, Gerard RD. Adenoviral targeting of gene expression to tumors. Cancer Gene Ther 2010; 17: 375-386.
29. Ocak I, Baluk P, Barrett T, McDonald DM, Choyke P. The biologic basis of in vivo angiogenesis imaging. Front Biosci 2007; 12: 3601-3616.
30. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002; 62: 6132-6140. (Pubitemid 35244462)
31. Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys 2002; 54: 1479-1484. (Pubitemid 35380052)
32. Ran S, Gao B, Duffy S, Watkins L, Rote N, Thorpe PE. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Res 1998; 58: 4646-4653. (Pubitemid 28480630)
33. Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res 2005; 11: 1551-1562. (Pubitemid 40315240)
34. Huang X, Bennett M, Thorpe PE. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res 2005; 65: 4408-4416. (Pubitemid 40775680)
35. Luster TA, He J, Huang X, Maiti SN, Schroit AJ, de Groot PG et al. Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. J Biol Chem 2006; 281: 29863-29871. (Pubitemid 44536995)
36. Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J et al. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res 2008; 14: 1377-1385. (Pubitemid 351413918)
37. Kanthou C, Tozer GM. Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies. Int J Exp Pathol 2009; 90: 284-294.
38. Tozer GM, Kanthou C, Baguley BC. Disrupting tumour blood vessels. Nat Rev Cancer 2005; 5: 423-435. (Pubitemid 40791485)
39. Michieli P. Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? Cell Cycle 2009; 8: 3291-3296.
40. Kerbel RS. Antiangiogenic therapy: a universal chemosensi-tization strategy for cancer? Science 2006; 312: 1171-1175. (Pubitemid 43801134)
41. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812-2816. (Pubitemid 23113507)
42. Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 1999; 286: 1568-1571.
43. Smith TA, Idamakanti N, Rollence ML, Marshall-Neff J, Kim J, Mulgrew K et al. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther 2003; 14: 777-787. (Pubitemid 36623514)
44. Smith TA, Idamakanti N, Marshall-Neff J, Rollence ML, Wright P, Kaloss M et al. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum Gene Ther 2003; 14: 1595-1604. (Pubitemid 37452870)
45. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805-4810. (Pubitemid 26187479)
46. Kopfler WP, Willard M, Betz T, Willard JE, Gerard RD, Meidell RS. Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 1994; 90: 1319-1327. (Pubitemid 24284453)
47. Brennan M, Davison PF, Paulus H. Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments. Science 1985; 229: 81-83. (Pubitemid 15018286)
48. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 1997; 275: 547-550. (Pubitemid 27051913)
49. Henry LJ, Xia D, Wilke ME, Deisenhofer J, Gerard RD. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol 1994; 68: 5239-5246. (Pubitemid 24226593)
50. Zinn KR, Douglas JT, Smyth CA, Liu HG, Wu Q, Krasnykh VN et al. Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5). Gene Ther 1998; 5: 798-808.
51. Bayo-Puxan N, Cascallo M, Gros A, Huch M, Fillat C, Alemany R. Role of the putative heparan sulfate glycosami-noglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J Gen Virol 2006; 87: 2487-2495.
52. Niu G, Xiong Z, Cheng Z, Cai W, Gambhir SS, Xing L et al. In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Mol Imaging Biol 2007; 9: 126-134. (Pubitemid 46705706)
53. Xiong Z, Cheng Z, Zhang X, Patel M, Wu JC, Gambhir SS et al. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med 2006; 47: 130-139. (Pubitemid 46768522)
54. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 2005; 79: 7478-7491. (Pubitemid 40756784)
55. Jonsson MI, Lenman AE, Frangsmyr L, Nyberg C, Abdullahi M, Arnberg N. Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells. J Virol 2009; 83: 3816-3825.